Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine
<i>Background</i>. Monoclonal antibodies (mAbs) directed against the calcitonin gene-related peptide (CGRP) or its receptor represented the first targeted and specialized approach to migraine prophylaxis. Nevertheless, they have been rarely considered in the treatment of vestibular migraine (VM). Ou...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI AG
2023-08-01
|
| Seria: | Medicina |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.mdpi.com/1648-9144/59/9/1560 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|